Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Ordinary Share $0.00001 Par Value
- Total 13F shares
- 62,986,284
- Total 13F value
- $602,166,380
- Share change
- +3,508,620
- Put/Call ratio
- 377%
- SEC-reported price per share
- $9.56
- Number of holders
- 114
- Value change
- +$31,622,746
- Number of buys
- 56
- Number of sells
- 50
- Shares outstanding
- 51,428,000
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q1 2022
Institutions
114
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G8807B106
Recent filing periods:
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
BAUPOST GROUP LLC/MA
13D/G signal
—
Evidence rows
15
Latest as of
31 Dec 2021
13F
Lead comparable stake: 27%
Showing 1-6 of 15 holder rows.
Quick read
BAUPOST GROUP LLC/MA leads the comparable SEC ownership view at 27%.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BAUPOST GROUP LLC/MA
27%
Madison Avenue Partners, LP
13%
VANGUARD GROUP INC
12%
ORBIMED ADVISORS LLC
12%
BlackRock Finance, Inc.
9.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAUPOST GROUP LLC/MA |
13F
Company
|
27%
|
$150,945,000
13,660,168 shares
|
— | 31 Dec 2021 |
| Madison Avenue Partners, LP |
13F
Company
|
13%
|
$73,461,000
6,648,025 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
12%
|
$69,613,000
6,299,823 shares
|
— | 31 Dec 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
12%
|
$66,019,000
5,974,535 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
9.7%
|
$55,276,000
5,002,363 shares
|
— | 31 Dec 2021 |
| Weiss Asset Management LP |
13F
Company
|
5.1%
|
$28,750,000
2,601,778 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
62,986,284
Rows available
114
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
109
Q1 2022 holders
114
Holder diff
5
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend